2 news items
Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease
CGTX
21 May 24
of research, Mary Hamby, Ph.D. and two leading experts: Everard (Jort) Vijverberg, MD, PhD, Staff Neurologist and CNS Trial
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's Disease
CGTX
22 Apr 24
of the Alzheimer Center Amsterdam and Neuroscience Amsterdam. "The KOL roundtable we conducted featured a panel of Alzheimer's disease expert
- Prev
- 1
- Next